Symptoms of COVID-19 and influenza may look the same. It can be difficult for clinicians to identify based on signs & symptoms alone and if left undiagnosed, may result in health complications or community spread.
With more than 1,000,000 deaths1 from COVID-19 reported so far—and half a million deaths on average from influenza every year—effective tools are needed to deliver rapid results to manage patient care early and effectively in emergency care settings.
The cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas® Liat® System is a multiplex real-time polymerase chain reaction (PCR) test that detects and differentiates SARS-CoV-2, influenza A and influenza B in 20 minutes from a single nasal sample and in just one test.
Relying on the rapid and accurate performance of cobas® SARS-CoV-2 & Influenza A/B, healthcare providers in emergency care settings now have the urgent answers they need to rule-in or rule-out these three infections.